Sep 4, 2014 Cellectar Biosciences Announces Acceptance of Investigational New Drug Application to Evaluate I-131-CLR1404 in Clinical Trials in Relapsed or Refractory Multiple Myeloma Learn More
Aug 20, 2014 Cellectar Biosciences Reports Second Quarter 2014 Financial Results and Recent Highlights Learn More
Aug 20, 2014 Cellectar Biosciences Announces Closing of Public Offering and Partial Exercise of Underwriter's Over-Allotment Option Learn More
Aug 18, 2014 Cellectar Biosciences to Host Conference Call on August 20th to Discuss Second Quarter 2014 Results and Provide Quarterly Update on Development Progress Learn More